Form 4: Ralph Alvarez Acquires LLY Stock Units

Director Ralph Alvarez acquired 12,566 stock units of Eli Lilly and Company (LLY) on May 18, 2026, as part of a deferred compensation plan.

Summary

• Director Ralph Alvarez acquired 12,566 shares of Eli Lilly and Company (LLY) common stock on May 18, 2026.
• The acquisition was made at a price of $988.09 per share, totaling 55,627.279 shares after the transaction.
• These shares were acquired as stock units under the Lilly Directors' Deferral Plan, in lieu of cash compensation.
• The stock units will be settled in shares of common stock upon the reporting person's separation from service.
• The reporting person disclaims beneficial ownership except to the extent of their pecuniary interest.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents a routine director stock acquisition under a deferred compensation plan rather than a significant strategic event or financial performance indicator.

Positives

• Director acquisition of company stock can signal confidence in the company's future prospects.
• The acquisition is part of a structured deferral plan, indicating a long-term perspective on compensation.

Negatives

• The filing does not provide information on the company's financial performance or strategic updates, focusing solely on a director's transaction.

Risks

• The value of the deferred stock units is subject to market fluctuations and the future performance of Eli Lilly and Company's stock.
• The reporting person's beneficial ownership is limited to their pecuniary interest, suggesting potential complexities in ownership structure.

Future Outlook

The acquired stock units will be settled in shares of common stock following the reporting person's separation from service, indicating a future transfer of ownership contingent on that event.

Management Comments

• The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.

Industry Context

StockSavvy.ai notes that insider transactions, particularly by directors, are closely watched by the market as potential indicators of management's view on the company's valuation and future performance. This acquisition by a director of Eli Lilly and Company, a major pharmaceutical firm, falls within a common practice of executive compensation and long-term incentive alignment.

Stakeholder Impact

• Shareholders: The acquisition itself does not immediately impact share count or market price, but it may be interpreted as a positive signal of director confidence.
• Employees: The deferred compensation plan structure is a component of executive compensation, indirectly affecting employee morale and retention strategies.
• Management: The transaction aligns the director's financial interests with those of shareholders through long-term equity ownership.

Next Steps

• Settlement of stock units in shares of common stock following the reporting person's separation from service.

Key Dates

Keywords

Form 4, Insider Trading, Eli Lilly, LLY, Stock Acquisition, Director Compensation, Deferred Compensation, Securities Exchange Act